Cite
18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446.
MLA
Koole, Michel, et al. “18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446.” Journal of Nuclear Medicine, vol. 60, no. 5, May 2019, pp. 683–90. EBSCOhost, https://doi.org/10.2967/jnumed.118.216747.
APA
Koole, M., Schmidt, M. E., Hijzen, A., Ravenstijn, P., Vandermeulen, C., Van Weehaeghe, D., Serdons, K., Celen, S., Bormans, G., Ceusters, M., Wei Zhang, Van Nueten, L., Kolb, H., de Hoon, J., & Van Laere, K. (2019). 18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446. Journal of Nuclear Medicine, 60(5), 683–690. https://doi.org/10.2967/jnumed.118.216747
Chicago
Koole, Michel, Mark E. Schmidt, Anja Hijzen, Paulien Ravenstijn, Corinne Vandermeulen, Donatienne Van Weehaeghe, Kim Serdons, et al. 2019. “18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446.” Journal of Nuclear Medicine 60 (5): 683–90. doi:10.2967/jnumed.118.216747.